Hemant Surgical Industries Limited manufactures, markets, imports, and exports surgical products, healthcare products & medical equipment and pharmaceutical products in India and internationally. The company offers healthcare & surgical disposables, includes jms meditape, infusion sets, scap vein set, blood transfusion set, pediatric iv, burette set, safecath silicone foley catheter, endotracheal tube, latex foley catheter, feather skin grafting blade, aero skin stapler, aero plus ecg electrodes, digital thermometer, nebulizer, and oxygen concentrator; and dialysis products, such as dialysis machine, refurbish dialysis machine, heparin, diaclean, citro h, iron sucrose injection, dialyzer, bicart, bibag, bloodline tubing, infusion set, bicarbonate mixture, ro plant, water tank, dialysis bed, dialysis chair, refurb ng dialysis machine, av fistula, on & off kit, lumen catheter, and hemodialysis concentrator. The company also offers radiology & criticare products, such as ultrasouch machine, digital radiography machine, X-ray machine, anesthesia machine, multipara monitor, ecg machine, defibrillator, and icu ventilator; and opthalmology products, including galilean and prismatic loupe, spot illuminator, surgical camera, ttl loupe, light source, slit lamp microscope, and operating microscope. In addition, the company offers surgical disposables, such as meditapes, intravenous infusion sets, and oximeters. Further, it provides a turnkey dialysis center, imaging and diagnostic center, modular intensive care unit, modular operation theater, oncology labs and treatment centers, blood bank, and dental clinic setup services. Hemant Surgical Industries Limited was founded in 1985 and is headquartered in Mumbai, India.
Metrics to compare | HEMT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHEMTPeersSector | |
---|---|---|---|---|
P/E Ratio | 47.7x | 38.6x | −0.6x | |
PEG Ratio | −2.14 | 0.12 | 0.00 | |
Price/Book | 6.1x | 4.1x | 2.6x | |
Price / LTM Sales | 3.6x | 2.7x | 3.4x | |
Upside (Analyst Target) | - | 24.1% | 37.6% | |
Fair Value Upside | Unlock | −6.7% | 5.6% | Unlock |